Complementary and alternative medications in the management of inflammatory bowel disease.
Study Design
- Tipo di studio
- Review
- Popolazione
- IBD patients
- Intervento
- Complementary and alternative medications in the management of inflammatory bowel disease. None
- Comparatore
- Conventional treatment
- Esito primario
- None
- Direzione dell'effetto
- Mixed
- Rischio di bias
- Unclear
Abstract
The use of complementary and alternative medications (CAM), products, and therapies not considered to be part of conventional medicine is common among patients with inflammatory bowel disease (IBD). Patients often turn to these therapies as they are considered natural and safe, with significant benefit reported beyond disease control. There is emerging evidence that some of these therapies may have anti-inflammatory activity; however, robust evidence for their efficacy in modulating disease activity is currently lacking. Patients often avoid discussing the use of CAM with their physicians, which may lead to drug interactions and/or reduced adherence with conventional therapy. It is important for physicians to be aware of the commonly used CAM and current evidence behind these therapies in order to better counsel their patients about their use in the management of IBD. This narrative review provides an overview of the evidence of the more commonly used CAM in patients with IBD.
TL;DR
An overview of the commonly used CAM and current evidence behind these therapies in patients with IBD is provided in order to better counsel their patients about their use in the management of IBD.
Used In Evidence Reviews
Similar Papers
The American journal of clinical nutrition · 1991
Omega-3 fatty acids in health and disease and in growth and development.
Journal of the American College of Nutrition · 2002
Omega-3 fatty acids in inflammation and autoimmune diseases.
The AAPS journal · 2013
Therapeutic roles of curcumin: lessons learned from clinical trials.
The American journal of gastroenterology · 2011
Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature.
Digestive diseases and sciences · 2005
Curcumin therapy in inflammatory bowel disease: a pilot study.
Molecular nutrition & food research · 2013